Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
6.31
+0.09 (1.45%)
At close: Jul 10, 2025, 4:00 PM
6.32
+0.01 (0.16%)
After-hours: Jul 10, 2025, 4:04 PM EDT
Bolt Biotherapeutics Stock Forecast
BOLT's stock price has decreased by -56.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts that cover Bolt Biotherapeutics stock have a consensus rating of "Buy" and an average price target of $50, which forecasts a 692.39% increase in the stock price over the next year. The lowest target is $20 and the highest is $80.
Price Target: $50 (+692.39%)
Analyst Consensus: Buy
* Price targets were last updated on May 20, 2025.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +1,167.83% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $25 → $20 | Hold | Maintains | $25 → $20 | +216.96% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 25, 2025 |
| Stifel | Stifel | Hold Maintains $30 → $25 | Hold | Maintains | $30 → $25 | +296.20% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
Financial Forecast
Revenue This Year
4.40M
from 7.69M
Decreased by -42.78%
Revenue Next Year
5.46M
from 4.40M
Increased by 24.14%
EPS This Year
-24.00
from -33.06
EPS Next Year
-19.04
from -24.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3M | 15.9M | 38.4M | ||
| Avg | 4.4M | 5.5M | 18.8M | ||
| Low | 2.9M | n/a | 294,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -31.2% | 261.9% | 603.2% | ||
| Avg | -42.8% | 24.1% | 244.4% | ||
| Low | -61.8% | - | -94.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -21.42 | -13.65 | -6.72 | ||
| Avg | -24.00 | -19.04 | -6.73 | ||
| Low | -25.09 | -27.83 | -6.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.